TRVI vs TYRA Stock Comparison

TRVI currently leads TYRA in this stock comparison, with AIQ scores of 63 vs 49. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 14 points
TRVI
Healthcare
vs
TYRA
Healthcare
TRVI
Trevi Therapeutics, Inc.
Leads
Price
$13.65
Day move
+0.22%
AIQ Score
63/100
Best edge
Momentum
Sector
Healthcare
TYRA
Tyra Biosciences, Inc.
Price
$20.03
Day move
+1.32%
AIQ Score
49/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between TRVI and TYRA?

TRVI leads the current stock comparison as Trevi Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Trevi Therapeutics, Inc. vs Tyra Biosciences, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 59/66 fields· Moderate confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

TRVI leads

TRVI leads by 14 AIQ points, primarily on Momentum and Quality, but the lead has narrowed from 18 points over 30 sessions.

Competitive: 3 of 4 evidence groups support TRVI, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 3 of 4Comparison trend: Weakening
TRVI

Trevi Therapeutics, Inc.

Leads
AIQ Score
63/100
AIQ Edge Score
10/10
TYRA

Tyra Biosciences, Inc.

AIQ Score
49/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors TRVI over TYRA, 63 versus 49 as of Nov 15, 2026. TRVI's advantage is driven primarily by stronger momentum and quality. TRVI also shows the stronger technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor TRVI today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. TRVI lead: Weakening — the AIQ differential moved from 18 to 14 points over 30 sessions.

Compare Trevi Therapeutics, Inc. and Tyra Biosciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

TRVI
+1187.7%
TYRA
-25.3%

Price return comparison

Growth of $10,000, price only

TRVI $128,774 · TYRA $7,475

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare TRVI and TYRA against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

TRVI advantage
0
TYRA advantage
  • Momentum52 vs 27
    TRVI +25
  • Quality82 vs 75
    TRVI +7
  • Risk Resilience51 vs 45
    TRVI +6

3 of 4 evidence groups favor TRVI. TRVI’s edge is concentrated in momentum and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

TRVI+3 AIQ

Largest factor move: Momentum +6

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
TYRA-1 AIQ

Largest factor move: Momentum -3

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

TRVI's lead widened by 4 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — TRVI and TYRA both carry a full feed there.

The central trade-off

TRVI (Trevi Therapeutics, Inc.): the stronger current systematic profile, led by momentum and quality.

TYRA (Tyra Biosciences, Inc.): the counter-case, on fundamentals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

TRVI

TRVI on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

TYRA

TYRA on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

TRVI

TRVI on the Momentum factor, by 25 points.

Lower downside

TRVI

TRVI on Risk Resilience, by 6 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureTRVITYRANote
Implied upside to target—+118.5%Level
Target dispersion—+61.7%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1115Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor TRVI. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreTRVI63 vs 49
FundamentalsTYRArevenue growth 0% vs 0%; EPS growth -18.2% vs -7.2%; TTM ROE -7.1% vs -7.4%; gross margin 0% vs 0%; operating margin 0% vs 0%
ValuationNot coveredNot covered
TechnicalsTRVIPrice vs 50-day -2.7% vs -7.9%; vs 200-day -6% vs -31.9%
Risk ResilienceTRVIRisk Resilience 51 vs 45
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of TRVI and TYRA and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 14 points. (supports the conclusion holding)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TRVI.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

TRVI lead: Weakening — the AIQ differential moved from 18 to 14 points over 30 sessions.

May 27TRVI leads above the line · TYRA leads belowNov 13
Today
TRVI +14
63 vs 49
7 sessions ago
TRVI +17
62 vs 45
30 sessions ago
TRVI +18
58 vs 40
90 sessions ago
TRVI +29
79 vs 50

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

TRVIConflicted

2 bullish / 4 bearish / 2 neutral, conflicted

Only TRVI

  • Beta Spike Warning — bearish, risk_regime, long horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
TYRA

0 bullish / 5 bearish / 2 neutral

Only TYRA

  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

Both carry 5 more signals that do not separate them: Death Cross Active, ADX Trend Weakening, ATR Expansion - Breakout Mode, Downtrend Structure Active, Low Volume Rally Warning.

TRVI leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

TRVIConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.22%, AIQ +3 points).

TYRADivergence

Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +1.32%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1TYRA closes the Momentum gap — currently 25 points behind, the largest single contributor to TRVI's edge.
  2. 2TYRA's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3TRVI's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 14-point move would eliminate TRVI's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

TYRA leads on balance
MetricTRVITYRA
Revenue growth (YoY)0%0%
EPS growth (YoY)-18.2%-7.2%
Gross margin0%0%
Operating margin0%0%
Return on equity (TTM)-7.1%-7.4%
Debt to equity00.01

Performance

TRVI leads 4 of 6 windows
MetricTRVITYRA
1 week (5 sessions)-4.7%-5.3%
1 month (20 sessions)14.9%8.1%
3 months (63 sessions)-26.1%-23.6%
6 months (126 sessions)-3.9%-45.9%
Year to date9%-23.8%
1 year (252 sessions)15.2%29.4%

Technicals

TRVI has the stronger structure
MetricTRVITYRA
RSI (14)48.542.8
ADX (14)22.712.1
Price vs 50-day-2.7%-7.9%
Price vs 200-day-6%-31.9%
Volatility (1M, annualized)76.9%51.8%

Risk

TRVI is the more resilient
MetricTRVITYRA
Beta1.380.53
Sharpe ratio0.520.65
Sortino ratio0.81
Max drawdown-39.1%-53.2%
Current drawdown-30%-49.4%
Annualized volatility59.3%67.9%
Value at risk (95%)-5.4%-5.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, TRVI or TYRA?

On the Algovestiq AIQ Score, TRVI is the stronger of the two as of Nov 15, 2026, scoring 63 against TYRA's 49. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is TRVI or TYRA the better buy right now?

TRVI carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor TRVI over TYRA?

The composite weights Quality, Value, Momentum and Risk Resilience. TRVI leads Momentum by 25 points; TRVI leads Quality by 7 points; TRVI leads Risk Resilience by 6 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, TRVI or TYRA?

Analyst price targets imply not covered upside for TRVI and +118.5% for TYRA. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, TRVI or TYRA?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, TRVI or TYRA?

TYRA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, TRVI or TYRA?

TRVI on the Momentum factor, by 25 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, TRVI or TYRA?

TRVI is the more resilient of the two, so the other name carries the higher downside risk. TRVI on Risk Resilience, by 6 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is TRVI more profitable than TYRA?

Margin data is not comparable for both names in the current snapshot.

Is TRVI's lead over TYRA getting stronger or weaker?

TRVI lead: Weakening — the AIQ differential moved from 18 to 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the TRVI vs TYRA verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TYRA closes the Momentum gap — currently 25 points behind, the largest single contributor to TRVI's edge; TYRA's Death Cross Active resolves — a bearish trend rule currently active against it; TRVI's conflicting signal state resolves bearish — it currently carries 2 bullish and 4 bearish rules at once; the narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 14-point move would eliminate TRVI's advantage entirely.

What do the current signals say about TRVI and TYRA?

TRVI: 2 bullish / 4 bearish / 2 neutral, conflicted. TYRA: 0 bullish / 5 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on TRVI is Death Cross Active (bearish, long horizon). On TYRA it is Death Cross Active (bearish, long horizon).

Compare TRVI and TYRA with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.